View in EDS HTML Full Text PDF Full Text

Pembrolizumab in Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome.

Saved in:
Bibliographic Details
Title: Pembrolizumab in Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome.
Authors: Elghawy O; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Sussman JH; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Yang AG; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Thomas CJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Carter JS; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Landsburg DJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Svoboda J; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Kim E; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia., Rook AH; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia., Chung J; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia., Plastaras JP; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia., LaRiviere M; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia., Hubbeling H; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia., Chelius M; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia., Nasta SD; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Chong EA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Schuster SJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Barta SK; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.
Source: JAMA dermatology [JAMA Dermatol] 2025 Jun 01; Vol. 161 (6), pp. 656-658.
Publication Type: Journal Article
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40172900
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Pembrolizumab in Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Elghawy+O%22">Elghawy O</searchLink>; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Sussman+JH%22">Sussman JH</searchLink>; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Yang+AG%22">Yang AG</searchLink>; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Thomas+CJ%22">Thomas CJ</searchLink>; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Carter+JS%22">Carter JS</searchLink>; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Landsburg+DJ%22">Landsburg DJ</searchLink>; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Svoboda+J%22">Svoboda J</searchLink>; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Kim+E%22">Kim E</searchLink>; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Rook+AH%22">Rook AH</searchLink>; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Chung+J%22">Chung J</searchLink>; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Plastaras+JP%22">Plastaras JP</searchLink>; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia.<br /><searchLink fieldCode="AU" term="%22LaRiviere+M%22">LaRiviere M</searchLink>; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Hubbeling+H%22">Hubbeling H</searchLink>; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Chelius+M%22">Chelius M</searchLink>; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Nasta+SD%22">Nasta SD</searchLink>; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Chong+EA%22">Chong EA</searchLink>; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Schuster+SJ%22">Schuster SJ</searchLink>; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Barta+SK%22">Barta SK</searchLink>; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101589530%22">JAMA dermatology</searchLink> [JAMA Dermatol] 2025 Jun 01; Vol. 161 (6), pp. 656-658.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101589530 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2168-6084 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221686068%22">21686068 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Dermatol <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40172900
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1001/jamadermatol.2025.0251
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 656
    Titles:
      – TitleFull: Pembrolizumab in Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Elghawy O
      – PersonEntity:
          Name:
            NameFull: Sussman JH
      – PersonEntity:
          Name:
            NameFull: Yang AG
      – PersonEntity:
          Name:
            NameFull: Thomas CJ
      – PersonEntity:
          Name:
            NameFull: Carter JS
      – PersonEntity:
          Name:
            NameFull: Landsburg DJ
      – PersonEntity:
          Name:
            NameFull: Svoboda J
      – PersonEntity:
          Name:
            NameFull: Kim E
      – PersonEntity:
          Name:
            NameFull: Rook AH
      – PersonEntity:
          Name:
            NameFull: Chung J
      – PersonEntity:
          Name:
            NameFull: Plastaras JP
      – PersonEntity:
          Name:
            NameFull: LaRiviere M
      – PersonEntity:
          Name:
            NameFull: Hubbeling H
      – PersonEntity:
          Name:
            NameFull: Chelius M
      – PersonEntity:
          Name:
            NameFull: Nasta SD
      – PersonEntity:
          Name:
            NameFull: Chong EA
      – PersonEntity:
          Name:
            NameFull: Schuster SJ
      – PersonEntity:
          Name:
            NameFull: Barta SK
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2025 Jun 01
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2168-6084
          Numbering:
            – Type: volume
              Value: 161
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: JAMA dermatology
              Type: main
ResultId 1